A novel ultra-sensitive method for the detection of FGFR3 mutations in urine of bladder cancer patients – Design of the Urodiag® PCR kit for surveillance of patients with non-muscle-invasive bladder cancer (NMIBC)

BACKGROUND: We have recently developed a highly accurate urine-based test, named Urodiag®, associating FGFR3 mutation and DNA methylation assays for recurrence surveillance in patients with low-, intermediate-, and high-risk NMIBC. Previously, the detection of four FGFR3 mutations (G372C, R248C, S24...

Descripción completa

Detalles Bibliográficos
Autores principales: Roperch, Jean-Pierre, Hennion, Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247276/
https://www.ncbi.nlm.nih.gov/pubmed/32448160
http://dx.doi.org/10.1186/s12881-020-01050-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247276/
https://www.ncbi.nlm.nih.gov/pubmed/32448160
http://dx.doi.org/10.1186/s12881-020-01050-w

Ejemplares similares